Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;11(12):3238-3245.
doi: 10.1002/acn3.52231. Epub 2024 Nov 2.

Motor phenotypes associated with genetic neurodevelopmental disorders

Affiliations

Motor phenotypes associated with genetic neurodevelopmental disorders

Alexandra Santana Almansa et al. Ann Clin Transl Neurol. 2024 Dec.

Abstract

Objective: There is a growing number of monogenic disorders implicated in neurodevelopmental disorders (NDDs), including autism spectrum disorder and intellectual disability. Motor impairment is frequently seen in these disorders, although not clearly defined. We aimed to characterize the motor phenotype of genetic NDDs.

Methods: We analyzed data from Simons Searchlight, collecting information on patients with genetic NDDs. Data analyzed included Vineland Adaptive Behavior Scales Second Edition (Vineland-II) motor standard scores, motor milestones and tone abnormalities.

Results: In total, 959 patients with 57 genetic disorders were included. Disorders associated with Vineland-II motor standard score <56 included GRIN2B-related disorder (mean standard score = 53.5), HNRNPH2-related disorder (mean standard score = 55.8) and SCN2A-related disorder (mean standard score = 49.9). The only genetic condition with a mean age of sitting unsupported ≥18 months was GRIN1-related disorder (mean age = 26.3 months). Genetic conditions with a mean age of walking independently ≥36 months included CTNNB1-related disorder (mean age = 37.4 months) and HNRNPH2-related disorder (mean age = 41.9 months). Tone abnormalities included hypotonia in 83% (577/696), hypertonia in 16% (112/696), a diagnosis of cerebral palsy (CP) in 10% (73/696) and a diagnosis specifically of spastic CP in 3% (23/696).

Interpretation: Patients with genetic NDDs have a spectrum of motor impairment, which warrant further characterization.

PubMed Disclaimer

Conflict of interest statement

SS: SS has received grants from NIH/NINDS; consulting fees from GLG, Guidepoint (which connected to a client, Fortress Biotech), Novartis, ExpertConnect, Orchard Therapeutics. WKC is on the board of directors of Prime Medicine and Rallybio.

Figures

Figure 1
Figure 1
Box plot of Vineland‐II motor standard scores in the cohort stratified by genetic disorder.
Figure 2
Figure 2
Box plot of the age of sitting in the cohort stratified by a genetic disorder.
Figure 3
Figure 3
Box plot of the age of walking in the cohort stratified by a genetic disorder. Note that there is a scale break to reflect that there is one data point with age of walking at 240 months pertaining to an individual with CSNK2A1 disorder.

References

    1. American Psychiatric Association . American Psychiatric Association, DSM‐5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM‐5. American Psychiatric Association; 2013.
    1. Srivastava S, Love‐Nichols JA, Dies KA, et al. Meta‐analysis and multidisciplinary consensus statement: exome sequencing is a first‐tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med. 2019;21(11):2413‐2421. - PMC - PubMed
    1. Srivastava S, Lewis SA, Cohen JS, et al. Molecular diagnostic yield of exome sequencing and chromosomal microarray in cerebral palsy: a systematic review and meta‐analysis. JAMA Neurol. 2022;79:1287‐1295. - PMC - PubMed
    1. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:8‐14. - PubMed
    1. Green D, Charman T, Pickles A, et al. Impairment in movement skills of children with autistic spectrum disorders. Dev Med Child Neurol. 2009;51(4):311‐316. - PubMed

Substances

LinkOut - more resources